EMA Authorised: Lonsurf (trifluridine;tipiracil hydrochloride) — Les Laboratoires Servier

View source ↗

Summary

EMA authorised Lonsurf (trifluridine and tipiracil) for colorectal neoplasms; decision dated 26/07/2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Neoplasms

Drugs mentioned

• Lonsurf (trifluridine/tipiracil)

Snippet

Status: Authorised. Therapeutic area: Colorectal Neoplasms. MAH: Les Laboratoires Servier. Decision date: 26/07/2023